Open Actively Recruiting

Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications

About

Brief Summary

To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.

Study Type
Observational
Phase
Phase IV

Eligibility

Gender
All
Healthy Volunteers
Yes
Minimum Age
N/A
Maximum Age
N/A

Inclusion Criteria:

  • Currently using one or more topical glaucoma antihypertensives
  • Self-described symptoms of ocular surface discomfort
  • Xiidra is being prescribed as part of the subject's standard care

Exclusion Criteria:

  • History of glaucoma filtration surgery, history of ocular surface surgery (pterygium, conjunctivoplasty, etc.),
  • current use of topical cyclosporine
  • current use of topical steroids
  • incisional ocular surgery within 6 months

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Study Stats
Protocol No.
19-000843
Category
Ophthalmology
Contact
DANIEL CORDOVA
Location
  • UCLA Fountain Valley
  • UCLA Pasadena
For Providers
NCT No.
NCT04354545
For detailed technical eligibility, visit ClinicalTrials.gov.